UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Knowing about retirement plan taxes is vital for maximizing your retirement benefits. Stay informed to make the most of your retirement plans.
19,944 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
ALPS Equal Sector Weight ETF (EQL) is delivering solid returns as SPY pulls back, but a crowded market still favors c...
Market observers say political shocks, energy costs, and shifting policy paths are creating a fragile backdrop for ho...
loandepot reports $108m loss for 2025, reflecting a tougher fourth quarter even as annual revenue and pull-through ma...
February 2025 delivered a clear set of high-yield savings options as banks competed for deposits. This story reviews ...
Alphabet's AI ambitions are under scrutiny as cloud momentum and big-capex raise the stakes. Here’s what investors sh...
In 2026, AI budgets surge while pilots fade. A four‑pillar playbook separates winners from the rest, focusing on data...
A premier eye care company delivers $5.1 billion in revenue, while a prominent investor quietly expands holdings. Her...
AI is reshaping big tech, but not all bets are the same. This guide weighs Microsoft and Amazon on AI power, cash flo...
Ulta Beauty beat earnings and revenue expectations in the latest quarter, but investors focused on margin pressure an...
Traders are turning toward three mid-cap miners as the tape says these growth stocks could ride higher metal prices a...
The ultrawealthy are shifting away from open houses toward private waitlists and subscription-style deals for luxury ...